Novo Nordisk (NVO) P/B (1999 - 2026)
Novo Nordisk (NVO) P/B from Nov 1, 1999 to Jul 21, 2026. The TTM Novo Nordisk (NVO) P/B is 6.99. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Novo Nordisk (NVO)
| Year | P/B | Change |
|---|---|---|
| 2026 | 6.99 | -5.68% |
| 2025 | 7.42 | -61.48% |
| 2024 | 19.25 | -92.24% |
| 2023 | 248.13 | +7.66% |
| 2022 | 230.48 | +871.25% |
| 2021 | 23.73 | -75.05% |
| 2020 | 95.11 | -9.80% |
| 2019 | 105.45 | +652.33% |
| 2018 | 14.02 | -21.19% |
| 2017 | 17.79 | +22.25% |
| 2016 | 14.55 | -33.50% |
| 2015 | 21.88 | +29.01% |
| 2014 | 16.96 | +439.18% |
| 2013 | 3.15 | +10.86% |
| 2012 | 2.84 | +36.09% |
| 2011 | 2.08 | +0.10% |
| 2010 | 2.08 | +71.14% |
| 2009 | 1.22 | +19.84% |
| 2008 | 1.02 | -22.69% |
| 2007 | 1.31 | +53.28% |
| 2006 | 0.86 | +114.98% |
| 2005 | 0.40 | +3.72% |
| 2004 | 0.38 | +32.47% |
| 2003 | 0.29 | +41.73% |
| 2002 | 0.20 | -27.93% |
| 2001 | 0.28 | +13.28% |
| 2000 | 0.25 | +36.93% |
| 1999 | 0.18 | N/A |
Comparison Novo Nordisk (NVO) P/B with competitors
Novo Nordisk (NVO) P/B is 6.99.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -90.22% |
| GRFS | Grifols SA | 0.79 | -88.71% |
| SNY | Sanofi | 1.27 | -81.84% |
| BIIB | Biogen Inc | 1.52 | -78.28% |
| PFE | Pfizer Inc | 1.55 | -77.87% |
| OGN | Organon & Company | 3.93 | -43.87% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -41.51% |
| GSK | GSK Plc | 4.37 | -37.50% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -13.65% |
| AZN | Astrazeneca plc | 6.20 | -11.36% |
| MRK | Merck & Co Inc | 6.68 | -4.50% |
| GILD | Gilead Sciences Inc | 6.94 | -0.78% |
| JNJ | Johnson & Johnson | 7.64 | +9.23% |
| NSRX | Nasus Pharma Ltd | 12.90 | +84.42% |
| MDCX | MDCorp | 15.34 | +119.31% |
| AMGN | AMGEN Inc | 21.17 | +202.66% |
| SCLX | Scilex Holding Company | 28.85 | +312.45% |
| LLY | Lilly(Eli) & Company | 32.94 | +370.93% |
| ABBV | Abbvie Inc | 50.46 | +621.40% |